Independent form guide. BrieflyGo is not affiliated with or endorsed by IRS, USCIS, SSA, DOL, or any U.S. government agency. Official forms are sourced from public government websites.

IRSCredits & Incentives (8800/8900 Series)

Official form guide

Form 8820: Orphan Drug Credit

IRS Form 8820 is the Orphan Drug Credit form used by partnerships, S corporations, estates, trusts, and other taxpayers to calculate and claim the credit for qualified clinical testing expenses. The credit rate is 25% (or 19.75% if the reduced credit election is made).

Need help with Form 8820?

Open it in the AI Editor for field guidance, checks, and PDF export.

Fillable formOpen in Editor->

Form Overview

IRS Form 8820 - Orphan Drug Credit

IRS Form 8820 is the Orphan Drug Credit form used by partnerships, S corporations, estates, trusts, and other taxpayers to calculate and claim the credit for qualified clinical testing expenses. The credit rate is 25% (or 19.75% if the reduced credit election is made).

Part I reports the qualified clinical testing expenses, the credit amount, and any reduced‑credit election; Part II lists each orphan drug’s generic name, designation application number, and designation date, plus allocation details for estates or trusts.

Risk Radar

Scan points
  • 1Failing to file Form 8820 when electing the reduced credit voids the election.
  • 2Electing the reduced credit but not filing Form 8820 with the original return.
  • 3Multiplying line 1 by the wrong percentage (using 25% instead of 19.75% for a reduced credit election).
  • 4Omitting the required statement that explains how the share of the credit on line 2a was calculated.
  • 5Leaving any orphan drug entry in Part II incomplete—missing generic name, designation number, or date.

Plain English

Form 8820 lets a business calculate the credit it gets for money spent on clinical testing of an orphan drug. It shows the total expenses, applies the 25% credit (or a lower rate if elected), and reports each drug’s name and designation details.

Submission Date

  • Filing date: 2018-09-27 23:00:08
  • Preparation window: collect IDs, supporting records, and signatures in advance.
  • Final review: verify names, dates, and required fields before submission.

AI co-pilot

Fill it faster. Catch mistakes before you file.

Explains confusing fields in plain English
Flags missing signatures, dates, IDs, and attachments
Keeps the PDF ready for editor, send, and proof flows
Open AI workspace->

Glossary Terms

Hover a term to preview the meaning.

What this form is for

  • Use this form when you are a partnership, S corporation, estate, trust, or other taxpayer needing to figure and claim the orphan drug credit or elect the reduced credit under section 280C.
  • Do not use it when you are not a partnership, S corporation, estate, or trust and your only source of the credit is from those pass‑through entities.
  • Check Form 3800 instead when you can report the orphan drug credit directly on the general business credit form.

Form selector

Use this form or another form?

Taxpayer is not a partnership, S corporation, estate, or trust and only receives credit through pass‑through entities

Orphan drug credit can be reported directly on the general business credit form

✓ Confirm no pass‑through credit remains

Form 3800

Credit includes wages also used for employer differential wage credit

Coordination between Form 8820 line 2a and Form 8932 is required

✓ Verify overlapping wage amounts

Form 8932

Individual taxpayer wants to claim orphan drug credit directly

Direct reporting avoids filing Form 8820

✓ Ensure you are not a partnership, S corporation, estate, or trust

Form 3800

Deadline or filing window

Not stated in the official source.

Checklist

What you need before filling it out

1

Line 1 – Qualified clinical testing expenses

Invoices, contracts showing expenses · Form 8820 Part I

⚠ Including non‑qualified expenses✕ High
2

Line 2a – Orphan drug credit amount

Calculation worksheet · Form 8820 line 2a

⚠ Applying wrong credit rate✕ Medium
3

Election question – Reduced credit under section 280C?

Election statement attached · Form 8820 line a

⚠ Failing to attach required statement✕ High
4

Line 2b – Overlap with employer differential wage credit

Form 8932 credit amount · Form 8820 line 2b

⚠ Double‑counting wages✕ Medium
5

Statement of share for controlled group

Controlled group statement · Attachment to Form 8820

⚠ Omitting statement for controlled group members✕ High

Before you submit

  1. 1Verify the revision date on the form reads September 2018.
  2. 2Confirm the name and identifying number match the tax return.
  3. 3Calculate qualified clinical testing expenses and ensure they are eligible.
  4. 4Multiply line 1 by the correct credit rate (25% or 19.75%) based on election.
  5. 5Indicate election for reduced credit on line a and attach the required statement if “Yes”.
  6. 6Attach the statement showing how the credit was figured and label it “See Attached”.
  7. 7If applicable, complete line 2b with the portion attributable to Form 8932.
  8. 8Ensure any required controlled‑group statement is attached.
  9. 9Review that no ineligible testing (outside U.S. without exception) is included.
  10. 10Sign the form if a signature line is present.

How to file this form

  1. 1Gather all qualified clinical testing expense documentation.
  2. 2Complete Part I of Form 8820, calculating line 1 and line 2a.
  3. 3Attach the credit calculation statement labeled “See Attached”.
  4. 4If electing reduced credit, check “Yes” on line a and attach the required election statement.
  5. 5File Form 8820 with the applicable tax return (e.g., Form 1120, 1120‑S, or 1041).
  6. 6Retain a copy of the completed Form 8820 and attachments for records.
  7. 7Submit the return and keep the IRS acknowledgment as proof of filing.

Known limitations

  1. 1Non‑partnership, non‑S corporation, non‑estate, and non‑trust taxpayers whose only orphan‑drug credit comes from those pass‑through entities are not required to file Form 8820 (Form p.3).
  2. 2Members of controlled groups or businesses under common control must attach a statement as required by the instructions (Form p.1).
  3. 3If the reduced credit election is not made, the credit amount must reduce the otherwise allowable deduction for qualified clinical testing expenses (Form p.4).

Field map

Compact field-by-field guide

6 fields

Entity Info

1 items

Taxpayer Name and TIN

Name and taxpayer ID of the entity claiming the credit.

Requiredtext

Credit Info

1 items

Credit Type

Type of credit or incentive being claimed.

Requiredselect

Calculation

2 items

Qualifying Amount

The base amount used to calculate the credit.

Requiredamount
Credit Amount

Calculated credit amount after applying formulas and limitations.

Requiredamount

Certification

1 items

Supporting Information

Detailed breakdown supporting the credit calculation.

text

Signatures

1 items

Signature

Sign and date the form.

Requiredsignature
This compact map shows typical fields for this form type. The AI Editor gives precise field guidance after you open the PDF.

Almost done reviewing the fields?

Fillable formOpen in Editor->
Current form status
IRS

The form shows Rev. September 2018 and directs users to www.irs.gov/Form8820 for the latest information; the credit rate was reduced to 25% for tax years beginning after 2017, with an optional reduced credit election.

What changed or needs a fresh check

  • Edition date — confirm the revision reads September 2018
  • Fee — Not stated in the official source
  • Mailing address — Not stated in the official source
  • Signature — Not stated in the official source

Quick Facts

Partnerships, S corporations, estates, trusts, and any other taxpayer claiming the orphan drug credit – including those electing the reduced credit under section 280C – must file IRS Form 8820.
Part I reports the qualified clinical testing expenses, the credit amount, and any reduced‑credit election; Part II lists each orphan drug’s generic name, designation application number, and designation date, plus allocation details for estates or trusts.
Not stated in the official source.
Not stated in the official source.
Not stated in the official source.
Enter the qualified clinical testing expenses on line 1 of Part I. Indicate a reduced‑credit election on line 2a, multiply line 1 by the appropriate rate, and attach a statement showing the calculation. Complete Part II for every orphan drug, providing its name, designation number, and designation date, and attach additional Part II pages as needed. File the completed form with the original timely‑filed tax return.

Fill Form 8820

AI-powered guidance for every field

Fillable formOpen in Editor->

Free to start / No account required

After you file

  1. 1Attach Form 8820 to the tax return before filing (Form p.1).
  2. 2Retain all books, records, and the attached statement for as long as they may become material in the administration of any Internal Revenue law (Form p.4).
  3. 3Report the calculated orphan drug credit on Form 3800, Part III, line 1h for most filers (Form p.1).
  4. 4Partnerships and S corporations must also report the credit amount on Schedule K (Form p.1).
  5. 5If the credit exceeds the allowable deduction, reduce the capitalized expense amount by the excess as instructed (Form p.4).

Sources

  • SRCForm p.1 — purpose: Use Form 8820 to figure and claim the orphan drug credit and to elect the reduced credit under section 280C.
  • SRCForm p.1 — credit rate: Multiply line 1 by 25% if “No” to reduced credit election, or by 19.75% if “Yes.”
  • SRCForm p.1 — attachment: Form 8820 must be attached to your tax return.
  • SRCForm p.1 — controlled groups: Members of controlled groups or businesses under common control must attach a statement.
  • SRCForm p.3 — limitation: Taxpayers not partnerships, S corporations, estates, or trusts, whose only credit source is those entities, are not required to file Form 8820; they may report on Form 3800.
  • SRCForm p.1 — partnership reporting: Partnerships and S corporations report the credit amount on Schedule K.
  • SRCForm p.1 — estate/trust reporting: Estates and trusts report the credit on Form 3800, Part III, line 1h.
  • SRCForm p.1 — Form 8932 reference: Enter the portion of the credit from Form 8932, line 2, attributable to wages on line 2a.
  • SRCForm p.4 — recordkeeping: Retain books and records as long as they may become material in the administration of any Internal Revenue law.
  • SRCForm p.4 — capitalized expenses: If credit exceeds the allowable deduction, reduce the capital account for the year by the excess amount.

Common confusion points

Do I need to file Form 8820 if I’m a corporation?

The form is primarily for partnerships, S corporations, estates, and trusts, and other taxpayers may report directly on Form 3800.

→ Verify your entity type and check the limitation for non‑pass‑through entities (Form p.3).

What credit rate should I use – 25% or 19.75%?

There is an election for a reduced credit under section 280C.

→ Look at line a; answer “Yes” to use 19.75% and “No” to use 25% (Form p.1).

Do I have to attach a statement if my business is in a controlled group?

Instructions require a statement for members of controlled groups or businesses under common control.

→ Confirm group status and attach the required statement (Form p.1).

Where do I report the credit if I’m a partnership?

Partnerships must report the amount on Schedule K and also on Form 3800.

→ Follow the line 4 instructions for partnerships and S corporations (Form p.1).

Can I include expenses that were funded by a grant?

Qualified clinical testing expenses exclude amounts funded by a grant, contract, or other person.

→ Exclude any grant‑funded amounts before calculating line 1 (Form p.3).

What if my qualified clinical testing expenses were capitalized?

Capitalized expenses require a reduction of the capital account if the credit exceeds the allowable deduction.

→ Reduce the capitalized amount by the excess credit as described (Form p.4).

Do I need to file Form 8820 if the only credit I receive is from a pass‑through entity?

Taxpayers not in the listed categories whose only source is a pass‑through are not required to file.

→ Use Form 3800 directly instead of Form 8820 (Form p.3).

How long must I keep the records for Form 8820?

Records must be retained as long as they may become material in tax administration.

→ Keep books and the attached statement for the required period (Form p.4).

Workflow map

Related forms and next steps

5 signals

Before

Form 8932 – calculates the credit attributable to wages that is entered on line 2a of Form 8820 (Form p.1).

Current

8820

After

Form 3800 – reports the orphan drug credit on Part III, line 1h for most filers (Form p.1).

Often used with

Form 8582-CR – determines the allowed credit allocation between an estate or trust and its beneficiaries (Form p.4).Schedule K – partnerships and S corporations report the orphan drug credit amount from Form 8820 on this schedule (Form p.1).Form 3800 – alternative filing for non‑pass‑through taxpayers whose only credit source is a partnership, S corporation, estate, or trust (Form p.3).

Questions about IRS Form 8820

What is IRS Form 8820 used for?

Form 8820 lets a business calculate the credit it gets for money spent on clinical testing of an orphan drug. It shows the total expenses, applies the 25% credit (or a lower rate if elected), and reports each drug’s name and designation details.

Who must file IRS Form 8820?

Partnerships, S corporations, estates, trusts, and any other taxpayer claiming the orphan drug credit – including those electing the reduced credit under section 280C – must file IRS Form 8820.

What information does IRS Form 8820 require?

Part I reports the qualified clinical testing expenses, the credit amount, and any reduced‑credit election; Part II lists each orphan drug’s generic name, designation application number, and designation date, plus allocation details for estates or trusts.

How do I complete IRS Form 8820?

Enter the qualified clinical testing expenses on line 1 of Part I. Indicate a reduced‑credit election on line 2a, multiply line 1 by the appropriate rate, and attach a statement showing the calculation. Complete Part II for every orphan drug, providing its name, designation number, and designation date, and attach additional Part II pages as needed. File the completed form with the original timely‑filed tax return.

Do I need to file Form 8820 if I’m a corporation?

The form is primarily for partnerships, S corporations, estates, and trusts, and other taxpayers may report directly on Form 3800. Verify your entity type and check the limitation for non‑pass‑through entities (Form p.3).

What credit rate should I use – 25% or 19.75%?

There is an election for a reduced credit under section 280C. Look at line a; answer “Yes” to use 19.75% and “No” to use 25% (Form p.1).

Do I have to attach a statement if my business is in a controlled group?

Instructions require a statement for members of controlled groups or businesses under common control. Confirm group status and attach the required statement (Form p.1).

Where do I report the credit if I’m a partnership?

Partnerships must report the amount on Schedule K and also on Form 3800. Follow the line 4 instructions for partnerships and S corporations (Form p.1).

Ready to get started?

Upload the form or open it in the AI Editor for intelligent guidance

Fillable formOpen in Editor->

Source transparency

Copyright & Licensing - US Government Forms

Independent guide

BrieflyGo links to and explains official public form sources. We are not a government agency, and this page is for general form guidance, not legal advice.

Public DomainCreated by the U.S. federal government. Not subject to copyright (17 USC § 105). Freely copyable without restriction.
Public DomainCreated by the U.S. federal government. Not subject to copyright (17 USC § 105). Freely copyable without restriction.
Public DomainCreated by the U.S. federal government. Not subject to copyright (17 USC § 105). Freely copyable without restriction.
Public DomainCreated by the U.S. federal government. Not subject to copyright (17 USC § 105). Freely copyable without restriction.
Verify current license terms with the source agency before reuse outside this platform.

Understand the agreement before you sign it.

Review risky clauses in plain English, fix the document, and keep it moving toward signature.

Review a contract free →